Funder: Gilead Sciences Research Scholars Program
Due Dates: February 19, 2027, 11:59 PM PST (Submission) | July 31, 2027, 11:59 PM PDT (Applicant notification)
Funding Amounts: Up to $130,000 USD over 2 years, including indirect costs
Summary: Supports early-career investigators researching breast, endometrial, ovarian, or small cell lung cancer in eligible countries in Asia, Latin America, and the Middle East.
Key Information: Proposals investigating Gilead products or interventional studies administering pharmaceutical drugs are ineligible.
Description
The Gilead Sciences Research Scholars Program in Oncology Solid Tumors International supports innovative research by emerging investigators. It seeks new perspectives that advance scientific understanding, address knowledge gaps, and drive breakthroughs in areas of unmet medical need. This international program focuses on breast, endometrial, ovarian, and small cell lung cancer.
The program emphasizes research addressing unmet patient needs and health inequities, including work in settings that might not typically receive funding. Its goal is to build a more inclusive research landscape and support discoveries that could lead to innovative interventions and clinical care. A Scientific Review Committee comprising leaders in solid tumor oncology selects proposals based on scientific merit, feasibility, and innovation.
